Po Hu

Dr. Po Hu


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2020 in Journal of Investigative Dermatology
Verified
Journal Article
Closed access
XYXiaoxuan Yu
Xiaoxuan Yu
LHLi Hui
Li Hui
MZMengyuan Zhu
Mengyuan Zhu
PHPo Hu
Po Hu
XLXiao Liu
Xiao Liu
HHHui hui
Hui hui

23 September 2023 in Science of The Total Environment
Verified
Journal Article
Closed access
MGMingtong Gao
Mingtong Gao
XGXiao Ge
Xiao Ge
YLYun Li
Yun Li
GZGege Zheng
Gege Zheng
JCJun Cai
Jun Cai
PHPo Hu
Po Hu

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
YQYingjie Qing
Yingjie Qing
LHLi Hui
Li Hui
YZYunzi Zhao
Yunzi Zhao
PHPo Hu
Po Hu
XWXiangyuan Wang
Xiangyuan Wang
HHHui hui
Hui hui
T‐cell malignancies are still difficult to treat due to a paucity of plans that target critical dependencies. Drug‐induced cellular senescence provides a permanent cell cycle arrest during tumorigenesis and cancer development, particularly when combined with senolytics to promote apoptosis of senescent cells, which is an innovation for cancer therapy. Here, our research found that wogonin, a well‐known natural flavonoid compound, not only had a potential to inhibit cell growth and proliferation but also induced cellular senescence in T‐cell malignancies with nonlethal concentration. Transcription activity of senescence‐suppression human telomerase reverse transcriptase (hTERT) and oncogenic C-MYC was suppressed in wogonin‐induced senescent cells, resulting in the inhibition of telomerase activity. We also substantiated the occurrence of DNA damage during the wogonin‐induced aging process. Results showed that wogonin increased the activity of senescence‐associated β‐galactosidase (SA‐β‐Gal) and activated the DNA damage response pathway mediated by p53. In addition, we found the upregulated expression of BCL‐2 in senescent T‐cell malignancies because of the antiapoptotic properties of senescent cells. Following up this result, we identified a BCL‐2 inhibitor Navitoclax (ABT‐263), which was highly effective in decreasing cell viability and inducing apoptotic cell death in wogonin‐induced senescent cells. Thus, the “one‐two punch” approach increased the sensibility of T‐cell malignancies with low expression of BCL‐2 to Navitoclax. In conclusion, our research revealed that wogonin possesses potential antitumor effects based on senescence induction, offering a better insight into the development of novel therapeutic methods for T‐cell malignancies.

24 March 2025 in Phytomedicine
Verified
Journal Article
Closed access
DWDe-Hui Wang
De-Hui Wang
XMXiao-Ni Ma
Xiao-Ni Ma
YWYan Wang
Yan Wang
YWYi-Xiao Wei
Yi-Xiao Wei
PHPo Hu
Po Hu
YPYang Pan
Yang Pan

9 August 2021 in Cell Communication and Signaling
Verified
Journal Article
Open access
PDF file
YQYINGJIE QING
YINGJIE QING
XWXiangyuan Wang
Xiangyuan Wang
HWHongzheng Wang
Hongzheng Wang
PHPo Hu
Po Hu
LHLi Hui
Li Hui
HHHui hui
Hui hui
Background: The positive transcription elongation factor b (P-TEFb) kinase activity is involved in the process of transcription. Cyclin-dependent kinase 9 (CDK9), a core component of P-TEFb, regulates the process of transcription elongation, which is associated with differentiation and apoptosis in many cancer types. Wogonin, a natural CDK9 inhibitor isolated fromScutellaria baicalensis.This study aimed to investigate the involved molecular mechanisms of wogonin on anti- chronic myeloid leukemia (CML) cells.Materials and methods: mRNA and protein levels were analysed by RT-qPCR and western blot. Flow cytometry was used to assess cell differentiation and apoptosis. Cell transfection, immunofluorescence analysis and co-immunoprecipitation (co-IP) assays were applied to address the potential regulatory mechanism of wogonin. KU-812 cells xenograftNOD/SCIDmice model was used to assess and verify the mechanism in vivo.Results: We reported that the anti-CML effects in K562, KU-812 and primary CML cells induced by wogonin were regulated by P-TEFb complex. We also confirmed the relationship between CDK9 and erythroid differentiation via knockdown the expression of CDK9. For further study the mechanism of erythroid differentiation induced by wogonin, co-IP experiments were used to demonstrate that wogonin increased the binding between GATA-1 and FOG-1 but decreased the binding between GATA-1 and RUNX1, which were depended on P-TEFb. Also, wogonin induced apoptosis and decreased the mRNA and protein levels of MCL-1 in KU-812 cells, which is the downstream of P-TEFb. In vivo studies showed wogonin had good anti-tumor effects in KU-812 xenograftsNOD/ SCIDmice model and decreased the proportion of human CD45+cells in spleens of mice. We also verified that wogonin exhibited anti-CML effects through modulating P-TEFb activity in vivo.Conclusions: Our study indicated a special mechanism involving the regulation of P-TEFb kinase activity in CML cells, providing evidences for further application of wogonin in CML clinical treatment.

11 December 2024 in Aging Cell
Verified
Journal Article
Open access
TZTian‐Yi Zhu
Tian‐Yi Zhu
PHPo Hu
Po Hu
YMYu‐Hui Mi
Yu‐Hui Mi
JZJun‐Li Zhang
Jun‐Li Zhang
AXAn‐Na Xu
An‐Na Xu
YPYang Pan
Yang Pan
While previous research has demonstrated the therapeutic efficacy of telomerase reverse transcriptase (TERT) overexpression using adeno‐associated virus and cytomegalovirus vectors to combat aging, the broader implications of TERT germline gene editing on the mammalian genome, proteomic composition, phenotypes, lifespan extension, and damage repair remain largely unexplored. In this study, we elucidate the functional properties of transgenic mice carrying the Tert transgene, guided by precise gene targeting into the Rosa26 locus via embryonic stem (ES) cells under the control of the elongation factor 1α (EF1α) promoter. The Tert knock‐in (TertKI) mice harboring the EF1α‐Tert gene displayed elevated telomerase activity, elongated telomeres, and extended lifespan, with no spontaneous genotoxicity or carcinogenicity. The TertKI mice showed also enhanced wound healing, characterized by significantly increased expression of Fgf7, Vegf, and collagen. Additionally, TertKI mice exhibited robust resistance to the progression of colitis induced by dextran sodium sulfate (DSS), accompanied by reduced expression of disease‐deteriorating genes. These findings foreshadow the potential of TertKI as an extraordinary rejuvenation force, promising not only longevity but also rejuvenation in skin and intestinal aging.